Stocks have rallied 177%, and while calling a top is the easiest thing to do, it might not be the most accurate, Cramer says.
VIDEO ON MSN MONEY
The Affordable Care Act implies a major reform in the public and private health insurance industry, which should increase demand for drugs and diagnostic equipment.
When President Barack Obama signed the Patient Protection and Affordable Care Act (PPACA), popularly known as "Obamacare," in March 2010, it received large amounts of praise and criticism. Most people seem to feel strongly one way or the other.
The polarizing response and the underlying reasons for it are quite intriguing and lie at the core beliefs of fundamental rights governing healthcare and the government's ability to enforce these rights. As research analysts, we consider how this impacts healthcare companies such as Abbott Labs (ABT), Pfizer (PFE), Merck (MRK) and Johnson & Johnson (JNJ).
It's time for a more realistic Plan B.
By Dan Caplinger
If you happen to be one of the winners of the Mega Millions jackpot from over the weekend, then by all means, skip the rest of this article. But for the rest of us losers -- which sadly includes yours truly -- it's time to get real about coming up with a plan for financial security that doesn't involve a 175 million-to-1 long shot.
Looking for the easy way out
I've got nothing against throwing away a dollar or two for the chance at winning millions. After all, it's not every day that you get a chance at a nine-figure payday -- and just the entertainment value alone of pondering the impact that a $640 million jackpot could have is worth something.
With its multi-channel approach, this firm is positioned at the forefront of today's changing retailing sector.
Nordstrom (JWN) is truly at the forefront of the evolving retail marketplace with the way it has embraced a multi-channel approach (department store, website with free shipping, off-price concept, and flash sale website HauteLook).
In addition, the company has built up its technology, distribution, and fulfillment infrastructure. In the near term, its investment spending will be a drag on the bottom line, but it is a long-term positive.
These US-listed investments can grab a large stake in global trends without the high fees and difficulty of investing in individual stocks abroad.
RDM Financial CEO Ron Weiner advises individuals to use ETFs and mutual funds for emerging-world exposure. He also likes sovereign debt in several emerging nations, he explains to MoneyShow.com's Kate Stalter.
Kate Stalter: Ron Weiner is the CEO and founder of RDM Financial Group. Ron, I understand that your investment philosophy involves quite a bit of exposure to emerging markets in some way. Can you tell us about that?
If the market's strong first quarter has you worried that investors are too bullish, try switching to defensive plays.
Ever since the 2008 market collapse and financial crisis, many investors have been suffering from a fear of heights.
Whenever the market goes on a nice upward run, they get fearful -- very fearful -- with the still-fresh scars of the '08 crash leading them to think that what goes up will certainly come down. That's what seems to be happening right now. With the market having a very strong first quarter, fears have arisen that things are too good, and sentiment is overly bullish.
As gas prices climb, automakers are scrambling to produce vehicles that won't give you much pain at the pump.
Shoppers turned their focus to smaller and more fuel-efficient vehicles, hoping to get some relief at the pump.
General Motors (GM) has 12 vehicles that do at least 30 mpg on the highway, and each of those was a sales winner in March. Combined, those 12 models contributed to 100,000 in sales for the month -- a record for GM.
Before the iPod, everyone's headphones were plugged into the Sony Walkman. But as the Walkman lost its relevance, Sony seemed to, as well.
Like Xerox (XRX), Kleenex, and Google (GOOG), Sony's (SNE) Walkman was the rare brand that was so popular it became the thing itself. The Japanese electronics giant was ubiquitous in other ways, too, and there was a time when it seemed as if everyone owned a Sony device, whether it was a television, a camcorder, or a stereo. But in the Apple (AAPL) iPad age, Sony seems to have all but disappeared from the marketplace for must-have gadgets.
What happened? And how can its new CEO, Kazuo Hirai, turn the company around? Here, a guide to Sony's woes:
The biotech has brighter prospects than its valuation suggests.
The largest biotech in the world lost its anemia drug monopoly in the U.S., but also announced good results for experimental drugs that have the potential to tap huge markets.
The question now is whether the good news outweighs the bad.
Stocks are at session highs after better-than-expected manufacturing reports in the U.S. and China.
Stock futures were a bit lower in pre-market trading Monday on renewed concern the eurozone has fallen into a recession after manufacturing data there disappointed.
The averages opened lower in what looked like a rocky beginning to the second quarter of trading. The averages soon found a level, however, where they sat and then built from. Construction spending for the month of February showed a decline, which analysts had not predicted. The ISM manufacturing report, though, was slightly ahead of expectations and the prices-paid report was also better, giving investors a reason to buy into the market. The averages soon turned positive and now stand near fresh recovery highs.
Investors bet on a gradual recovery in the housing sector.
While the turnaround is expected to be gradual, some companies associated with the industry have already started to shine.
The cosmetics giant needs to join forces with Coty or someone else.
Updated: 4:56 p.m. ET
Avon Products (AVP) is weakened and vulnerable -- and Coty pounced on the opportunity with an unsolicited $10 billion acquisition offer.
Avon immediately rejected the bid, but that didn't stop its shares from soaring Monday as investors sensed opportunity -- and negotiation. News of the offer pushed Avon's shares up $3.34 to $22.70. Volume topped 64 milion shares -- more than 10 times the daily average.
There are many problems with Coty's offer -- but that doesn't mean a merger of the cosmetics companies is a bad idea.
Amazon.com and Groupon are downgraded to 'neutral' at BofA/Merrill.
Monday's noteworthy upgrades include:
- Abercrombie & Fitch (ANF) upgraded to Buy from Hold at Brean Murray
- Canadian Natural (CNQ) upgraded to Overweight from Equal Weight at Barclays
- Concho Resources (CXO) upgraded to Buy from Hold at Deutsche Bank
- Kohl's (KSS) upgraded to Neutral from Underweight at JPMorgan
- Gap (GPS) upgraded to Above Average from Average at Caris
The generics drugmaker plans to tackle AstraZeneca's blockbuster antipsychotic drug Seroquel next.
Late last month, the U.S. Food and Drug Administration had approved Dr. Reddy's abbreviated new drug application for the generic drug. Seroquel is approved for the treatment of schizophrenia and bipolar mania.
With the "stress test" behind it, the clouds are clearing for this leader in the financial sector.
Our technical screens generally don't uncover many mega-cap companies like JPMorgan Chase & Co. (JPM), with sales of $111 billion and a market cap of $172 billion.
But the the stock is one of the strongest in the market now because investor perception of the ﬁnancial group has taken a sharp turn for the better. There are two main reasons for that.
The daily-deals company restates its fourth-quarter earnings
This is fairly unusual for a newly public company, since Wall Street has no history of quarterly results to go on and it's crucial for a new stock to build trust out of the gate. Unfortunately, Groupon scared many investors into thinking this company is at best sloppy and at worst corrupt -- resulting in a sharp sell-off that sent the company stock tumbling.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The US isn't strong enough not to care about them now. But one day it will be.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The major averages have slid to fresh lows after failing to retake their flat lines. The Russell 2000 (-0.9%) continues trailing other indices while the S&P 500 trades lower by 0.5%.
The industrial sector (-1.0%) is the weakest performer at this juncture with Boeing (BA 125.30, -3.24) trading lower by 2.5% after a 777 operated by Malaysia Airlines vanished over the South China Sea during the weekend. Boeing's notable weakness is also contributing to the ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|